Prot# XL999-203: A Phase 2 Study of XL999 Administered Intravenously to Subjects with Relapsed/Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/23/068/23/09

Funding

  • PPD Development (XL999-203 // XL999-203)
  • Exelixis Inc. (XL999-203 // XL999-203)